Market Cap 606.85M
Revenue (ttm) 75.39M
Net Income (ttm) -287.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -381.39%
Debt to Equity Ratio 0.00
Volume 3,363,400
Avg Vol 1,844,358
Day's Range N/A - N/A
Shares Out 266.16M
Stochastic %K 73%
Beta 2.07
Analysts Strong Sell
Price Target $8.63

Company Profile

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced with a lentiviral vector to express a novel anti-CD19 chimeric antigen receptor. It also develops obe-cel, which is in phase 1 to treat systemic lupus erythematosus, progressive multiple sclerosis, B-NHL...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 20 3829 6230
Address:
The Mediaworks, 191 Wood Lane White City, London, United Kingdom
MarketPro
MarketPro Aug. 19 at 1:51 PM
$AUTL Chart Update:
0 · Reply
Michael_garic
Michael_garic Aug. 19 at 1:38 PM
$AUTL $2.40 is the next sell wall...
0 · Reply
Michael_garic
Michael_garic Aug. 19 at 1:34 PM
$AUTL IOVA and AUTL hit 52 week high
1 · Reply
Michael_garic
Michael_garic Aug. 19 at 1:23 PM
$AUTL BNTX up 18%, no news specifically on BNTX but news from Moderna and Merck on positive MRNA results, personalized cancer vaccine potential.
0 · Reply
TricksterT
TricksterT Aug. 19 at 12:25 PM
$AUTL wow $XBI ripping on the $MRNA pump. Should bode well for us today!
2 · Reply
Michael_garic
Michael_garic Aug. 18 at 11:35 PM
$AUTL Good retail bidding around the $2.30 level. Short participation is very light at 23% of volume vs. 60%+ in July despite plenty of cheap shares at a 1.4% borrowing rate. Shorts are pretty much out of the picture for now.
1 · Reply
Dirk1969
Dirk1969 Aug. 18 at 6:48 PM
$AUTL Volume is increasing, the price remains stable, and upward momentum is strong.✅🫶
0 · Reply
TricksterT
TricksterT Aug. 18 at 5:51 PM
$AUTL 2.5 mill shares traded hands today with absolutely no movement. Bots maybe otherwise shorts doing a decent job today.
0 · Reply
Gugger
Gugger Aug. 18 at 3:33 PM
$AUTL i repeat myself, shorts u better cover, some bigger funds and institutions start to look at the stock on this low level 🤷‍♂️😉 ...
0 · Reply
Michael_garic
Michael_garic Aug. 18 at 2:56 PM
$AUTL the crystal ball says 2.50 this week
1 · Reply
Latest News on AUTL
Autolus Therapeutics Earnings Call Transcript: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Autolus Therapeutics Earnings Call Transcript: Q2 2026


Autolus Therapeutics Earnings release: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Autolus Therapeutics Earnings release: Q2 2026


Autolus Therapeutics Earnings release: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Autolus Therapeutics Earnings release: Q2 2026


Autolus Therapeutics Slides: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Autolus Therapeutics Slides: Q2 2026


Autolus Therapeutics Quarterly report: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Autolus Therapeutics Quarterly report: Q2 2026


Autolus Therapeutics reports Q2 EPS (15c), consensus (19c)

2026-08-11T11:20:11.000Z - 8 days ago

Autolus Therapeutics reports Q2 EPS (15c), consensus (19c)


Autolus Therapeutics Receives Prix Galien UK Award

Jun 12, 2026, 4:00 AM EDT - 2 months ago

Autolus Therapeutics Receives Prix Galien UK Award


Autolus Therapeutics Slides: Corporate presentation

May 21, 2026, 7:00 AM EDT - 3 months ago

Autolus Therapeutics Slides: Corporate presentation


Autolus Therapeutics reports Q1 EPS (27c), consensus (26c)

2026-05-14T12:45:01.000Z - 3 months ago

Autolus Therapeutics reports Q1 EPS (27c), consensus (26c)


Autolus Therapeutics Earnings Call Transcript: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Autolus Therapeutics Earnings Call Transcript: Q1 2026


Autolus Therapeutics Earnings release: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Autolus Therapeutics Earnings release: Q1 2026


Autolus Therapeutics Quarterly report: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Autolus Therapeutics Quarterly report: Q1 2026


Autolus Therapeutics Slides: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Autolus Therapeutics Slides: Q1 2026


Autolus Therapeutics to reduce workforce by approximately 13%

2026-04-29T22:04:39.000Z - 3 months ago

Autolus Therapeutics to reduce workforce by approximately 13%


Autolus Therapeutics Registration statement: Registration filing

Apr 13, 2026, 8:00 AM EDT - 4 months ago

Autolus Therapeutics Registration statement: Registration filing


Autolus Therapeutics Registration statement: Registration filing

Apr 13, 2026, 8:00 AM EDT - 4 months ago

Autolus Therapeutics Registration statement: Registration filing


Autolus Therapeutics Slides: Corporate presentation

Apr 13, 2026, 7:00 AM EDT - 4 months ago

Autolus Therapeutics Slides: Corporate presentation


Autolus Therapeutics files $150M mixed securities shelf

2026-04-13T10:06:09.000Z - 4 months ago

Autolus Therapeutics files $150M mixed securities shelf


Autolus Therapeutics Transcript: Status update

Apr 8, 2026, 1:00 PM EDT - 4 months ago

Autolus Therapeutics Transcript: Status update


Autolus Therapeutics Slides: Status update

Apr 8, 2026, 1:00 PM EDT - 4 months ago

Autolus Therapeutics Slides: Status update


Autolus Therapeutics Earnings Call Transcript: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 5 months ago

Autolus Therapeutics Earnings Call Transcript: Q4 2025


Autolus Therapeutics Annual report: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 5 months ago

Autolus Therapeutics Annual report: Q4 2025


Autolus Therapeutics Earnings release: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 5 months ago

Autolus Therapeutics Earnings release: Q4 2025


Autolus Therapeutics Slides: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 5 months ago

Autolus Therapeutics Slides: Q4 2025


Autolus Therapeutics reports Q4 EPS (34c), consensus (43c)

2026-03-27T11:36:34.000Z - 5 months ago

Autolus Therapeutics reports Q4 EPS (34c), consensus (43c)


Autolus Therapeutics initiated with a Buy at H.C. Wainwright

2026-02-17T11:11:16.000Z - 6 months ago

Autolus Therapeutics initiated with a Buy at H.C. Wainwright


Autolus Therapeutics Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 10 months ago

Autolus Therapeutics Earnings Call Transcript: Q3 2025


Autolus Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 8:30 AM EST - 10 months ago

Autolus Therapeutics Quarterly report: Q3 2025


Autolus Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 8:30 AM EST - 10 months ago

Autolus Therapeutics Earnings release: Q3 2025


Autolus Therapeutics Slides: Q3 2025

Nov 12, 2025, 8:30 AM EST - 10 months ago

Autolus Therapeutics Slides: Q3 2025


Autolus Therapeutics Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings Call Transcript: Q2 2025


Autolus Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Quarterly report: Q2 2025


Autolus Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings release: Q2 2025


Autolus Therapeutics Slides: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Slides: Q2 2025


Autolus Therapeutics Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings Call Transcript: Q1 2025


Autolus Therapeutics Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Quarterly report: Q1 2025


Autolus Therapeutics Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings release: Q1 2025


Autolus Therapeutics Slides: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Slides: Q1 2025


Autolus Therapeutics Transcript: Status Update

Apr 23, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Transcript: Status Update


Autolus Therapeutics Press release: Status Update

Apr 23, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Press release: Status Update


Autolus Therapeutics Slides: Status Update

Apr 23, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Slides: Status Update


Autolus Therapeutics Earnings Call Transcript: Q4 2024

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings Call Transcript: Q4 2024


Autolus Therapeutics Annual report: Q4 2024

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Annual report: Q4 2024


Autolus Therapeutics Earnings release: Q4 2024

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings release: Q4 2024


Autolus Therapeutics Slides: Q4 2024

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Slides: Q4 2024


Autolus Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Earnings Call Transcript: Q3 2024


Autolus Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Quarterly report: Q3 2024


Autolus Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Earnings release: Q3 2024


Autolus Therapeutics Slides: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Slides: Q3 2024


Autolus Therapeutics Transcript: FDA Announcement

Nov 11, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Transcript: FDA Announcement


Autolus Therapeutics Press release: FDA Announcement

Nov 11, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Press release: FDA Announcement


Autolus Therapeutics Slides: FDA Announcement

Nov 11, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Slides: FDA Announcement


Autolus Therapeutics Earnings Call Transcript: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Earnings Call Transcript: Q2 2024


Autolus Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Quarterly report: Q2 2024


Autolus Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Earnings release: Q2 2024


Autolus Therapeutics Slides: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Slides: Q2 2024


Autolus Therapeutics Transcript: Status Update

Jun 1, 2024, 9:30 AM EDT - 2 years ago

Autolus Therapeutics Transcript: Status Update


Autolus Therapeutics Earnings Call Transcript: Q1 2024

May 17, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Earnings Call Transcript: Q1 2024


Autolus Therapeutics Quarterly report: Q1 2024

May 17, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Quarterly report: Q1 2024


Autolus Therapeutics Earnings release: Q1 2024

May 17, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Earnings release: Q1 2024


Autolus Therapeutics Slides: Q1 2024

May 17, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Slides: Q1 2024


MarketPro
MarketPro Aug. 19 at 1:51 PM
$AUTL Chart Update:
0 · Reply
Michael_garic
Michael_garic Aug. 19 at 1:38 PM
$AUTL $2.40 is the next sell wall...
0 · Reply
Michael_garic
Michael_garic Aug. 19 at 1:34 PM
$AUTL IOVA and AUTL hit 52 week high
1 · Reply
Michael_garic
Michael_garic Aug. 19 at 1:23 PM
$AUTL BNTX up 18%, no news specifically on BNTX but news from Moderna and Merck on positive MRNA results, personalized cancer vaccine potential.
0 · Reply
TricksterT
TricksterT Aug. 19 at 12:25 PM
$AUTL wow $XBI ripping on the $MRNA pump. Should bode well for us today!
2 · Reply
Michael_garic
Michael_garic Aug. 18 at 11:35 PM
$AUTL Good retail bidding around the $2.30 level. Short participation is very light at 23% of volume vs. 60%+ in July despite plenty of cheap shares at a 1.4% borrowing rate. Shorts are pretty much out of the picture for now.
1 · Reply
Dirk1969
Dirk1969 Aug. 18 at 6:48 PM
$AUTL Volume is increasing, the price remains stable, and upward momentum is strong.✅🫶
0 · Reply
TricksterT
TricksterT Aug. 18 at 5:51 PM
$AUTL 2.5 mill shares traded hands today with absolutely no movement. Bots maybe otherwise shorts doing a decent job today.
0 · Reply
Gugger
Gugger Aug. 18 at 3:33 PM
$AUTL i repeat myself, shorts u better cover, some bigger funds and institutions start to look at the stock on this low level 🤷‍♂️😉 ...
0 · Reply
Michael_garic
Michael_garic Aug. 18 at 2:56 PM
$AUTL the crystal ball says 2.50 this week
1 · Reply
Michael_garic
Michael_garic Aug. 18 at 2:55 PM
$AUTL All we need to get to 4 bucks is an announcement of opening EU business....
4 · Reply
Merlintrader
Merlintrader Aug. 18 at 10:56 AM
Autolus Therapeutics ($AUTL) Stock Hub: AUCATZYL Launch, Gross Margin and CAR-T Expansion https://www.merlintrader.com/autolus-therapeutics-stock-hub/
0 · Reply
TricksterT
TricksterT Aug. 18 at 10:46 AM
Alphabet Inc. Takes Position in Autolus Therapeutics PLC Sponsored ADR $AUTL why not post for new buyers to see. https://www.marketbeat.com/instant-alerts/filing-alphabet-inc-takes-position-in-autolus-therapeutics-plc-sponsored-adr-autl-2026-08-18/
1 · Reply
Dirk1969
Dirk1969 Aug. 18 at 10:44 AM
$AUTL An attractive acquisition target for a major pharmaceutical company looking to expand into England.✅📈
0 · Reply
Michael_garic
Michael_garic Aug. 17 at 11:39 PM
$AUTL Bidding was strong going into the last 15 minutes of trading today... good sign, I think? Short sellers have been quiet the last week with short share of volume at historical lows, 27.5% vs. 60%+ in the last few weeks leading up to earnings. Shares available to short appear to be plentiful and cheap, borrowing cost is at 1.6%. Shorts don't appear as confident as they were in July where they were building sell walls at $1.40. Most are deep underwater if they haven't already covered. Will be an interesting week.
1 · Reply
Michael_garic
Michael_garic Aug. 17 at 9:12 PM
$AUTL who are the AUTL shareholders? Category Shares (approx.)% of Total Outstanding Hedge Funds ~49.5 million 18.6% Includes Armistice, Renaissance, etc VC / PE Firms ~35.4 million 13.3% Includes Blackstone, Tetragon-related, etc. Institutions ~35.1 million 13.2% Public Companies ~33.3 million 12.5% Primarily BioNTech SE Private Companies ~31.7 million 11.9% Includes Syncona-related and similar Insiders ~1.5 million 0.57% Officers & directors only General Public / Retail~79.6 million 29.9% Free-float retail & other publicTotal~266.1 million≈ 100%
1 · Reply
Dirk1969
Dirk1969 Aug. 17 at 7:57 PM
$AUTL ✅📈 https://www.nice.org.uk/news/articles/nice-recommends-uk-developed-next-generation-immunotherapy-for-blood-cancer
1 · Reply
Michael_garic
Michael_garic Aug. 17 at 6:32 PM
$AUTL what??? no poop memes from nananananannonononon?
0 · Reply
Michael_garic
Michael_garic Aug. 17 at 6:28 PM
$AUTL these are not new shares just a change in reporting. MarketBeat and similar sites often use formulaic language. In the Q2 2026 13F: They completely exited their Century Therapeutics (IPSC) position. AUTL ADSs became 100% of the reported 13F portfolio. The aggregator therefore highlighted the continuing 16.64 million AUTL ADS holding as a “new stake” or the main activity, even though the share count itself did not newly appear. There is no public announcement or filing indicating that Syncona converted a large block of ordinary shares into ADSs in Q2 2026 (or that the 13F figure reflects a reclassification). The 13F is simply continuing to report the ADS portion they already held. Bottom line: The 16.64 million is the ongoing ADS holding, not a fresh acquisition and not the result of an ADR classification change.
1 · Reply
pc247cz
pc247cz Aug. 17 at 6:17 PM
0 · Reply
Dirk1969
Dirk1969 Aug. 17 at 3:19 PM
$AUTL ✅👇
2 · Reply
4breaker
4breaker Aug. 17 at 2:45 PM
$AUTL We’re going to destroy you short sellers. Get out before you regret it even more.
0 · Reply